Literature DB >> 8777996

Determinants of a normal (versus impaired) oral glucose tolerance after combined pancreas-kidney transplantation in IDDM patients.

F Pfeffer1, M A Nauck, S Benz, A Gwodzinski, R Zink, M Büsing, H D Becker, U T Hopt.   

Abstract

After successful pancreas transplantation, insulin-dependent diabetic patients are characterized by a normal or at worst impaired oral glucose tolerance (World Health Organisation criteria). It is not known which pathophysiological mechanisms cause the difference between normal and impaired oral glucose tolerance. Therefore, we studied 41 patients after successful combined pancreas-kidney transplantation using stimulation in the fasting state with oral glucose (75 g), intravenous glucose (0.33 g/kg) and glucagon bolus injection (1 mg i.v.). Glucose (glucose oxidase), insulin and C-peptide (immunoassay) were measured. Repeated-measures analysis of variance and multiple regression analysis were used to analyse the results which showed: 28 patients had a normal, and 13 patients had an impaired oral glucose tolerance. Impaired oral glucose tolerance was associated with a greatly reduced early phase insulin secretory response (insulin p < 0.0001; C-peptide p = 0.037). Age (p = 0.65), body mass index (p = 0.94), immunosuppressive therapy (cyclosporin A p = 0.84; predniso(lo)ne p = 0.91; azathioprine p = 0.60) and additional clinical parameters were not different. Reduced insulin secretory responses in patients with impaired oral glucose tolerance were also found with intravenous glucose or glucagon stimulations. Exocrine secretion (alpha-amylase in 24-h urine collections) also demonstrated reduced pancreatic function in these patients (-46%; p = 0.04). Multiple regression analysis showed a significant correlation of 120-min glucose with ischaemia time (p = 0.003) and the number of HLA-DR mismatches (p = 0.026), but not with HLA-AB-mismatches (p = 0.084). In conclusion, the pathophysiological basis of impaired oral glucose tolerance after pancreas transplantation is a reduced insulin secretory capacity. Transplant damage is most likely caused by perioperative influences (ischaemia) and by the extent of rejection damage related, for example, to DR-mis-matches.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8777996     DOI: 10.1007/bf00400678

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  33 in total

1.  Worsening to diabetes in men with impaired glucose tolerance ("borderline diabetes").

Authors:  R J Jarrett; H Keen; J H Fuller; M McCartney
Journal:  Diabetologia       Date:  1979-01       Impact factor: 10.122

2.  Basal and nutrient-stimulated pancreatic and gastrointestinal hormone concentrations in type-1-diabetic patients after successful combined pancreas and kidney transplantation.

Authors:  M A Nauck; M Büsing; C Orskov; E G Siegel; J Talartschik; A Baartz; T Baartz; H Hölzer; U T Hopt; R Ebert
Journal:  Clin Investig       Date:  1992-01

3.  Preserved incretin effect in type 1 diabetic patients with end-stage nephropathy treated by combined heterotopic pancreas and kidney transplantation.

Authors:  M A Nauck; M Büsing; C Orskov; E G Siegel; J Talartschik; A Baartz; T Baartz; U T Hopt; H D Becker; W Creutzfeldt
Journal:  Acta Diabetol       Date:  1993       Impact factor: 4.280

4.  Effects of pancreas transplantation on postprandial glucose metabolism.

Authors:  H Katz; M Homan; J Velosa; P Robertson; R Rizza
Journal:  N Engl J Med       Date:  1991-10-31       Impact factor: 91.245

5.  The Bedford survey: ten year mortality rates in newly diagnosed diabetics, borderline diabetics and normoglycaemic controls and risk indices for coronary heart disease in borderline diabetics.

Authors:  R J Jarrett; P McCartney; H Keen
Journal:  Diabetologia       Date:  1982-02       Impact factor: 10.122

6.  The ten-year follow-up of the Bedford survey (1962-1972): glucose tolerance and diabetes.

Authors:  H Keen; R J Jarrett; P McCartney
Journal:  Diabetologia       Date:  1982-02       Impact factor: 10.122

Review 7.  Pancreas transplantation in humans with diabetes mellitus.

Authors:  R P Robertson
Journal:  Diabetes       Date:  1991-09       Impact factor: 9.461

8.  Technique of simultaneous renal pancreatoduodenal transplantation with urinary drainage of pancreatic secretion.

Authors:  D D Nghiem; R J Corry
Journal:  Am J Surg       Date:  1987-04       Impact factor: 2.565

9.  Fresh human islet transplantation to replace pancreatic endocrine function in type 1 diabetic patients. Report of six cases.

Authors:  C Socci; L Falqui; A M Davalli; C Ricordi; S Braghi; F Bertuzzi; P Maffi; A Secchi; F Gavazzi; M Freschi
Journal:  Acta Diabetol       Date:  1991       Impact factor: 4.280

10.  Impaired glucose tolerance as a disorder of insulin action. Longitudinal and cross-sectional studies in Pima Indians.

Authors:  S Lillioja; D M Mott; B V Howard; P H Bennett; H Yki-Järvinen; D Freymond; B L Nyomba; F Zurlo; B Swinburn; C Bogardus
Journal:  N Engl J Med       Date:  1988-05-12       Impact factor: 91.245

View more
  2 in total

Review 1.  Management of hyperglycaemia after pancreas transplantation: are new immunosuppressants the answer?

Authors:  Francesca M Egidi
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 2.  Glucose metabolism after pancreas-kidney transplantation.

Authors:  Elizabeth Diakoff
Journal:  Curr Diab Rep       Date:  2008-08       Impact factor: 4.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.